期刊文献+

纯化重组霍乱毒素B亚单位与天然霍乱毒素B亚单位性质的对比研究 被引量:2

Studies on the Characters of the Recombinant Cholera Toxin B Subunit in Comparison with the Native Cholera Toxin B Subunit
在线阅读 下载PDF
导出
摘要 霍乱毒素B亚单位(BS)已用于新型口服霍乱疫苗、佐剂及蛋白质载体,但成本高,来源困难.用重组霍乱毒素B亚单位(rBS)代替BS可克服上述缺点.rBS用于上述目的前必须证实其在物理、化学及免疫学性质方面与天然同类产品的一致性.用亲和层析法从各批次大罐发酵所获工程菌E.coliMM2(pMM-CTB)培养物上清中制备得到了小批量rBS纯品,在同等条件下与BS(Sig-ma公司产品)进行理化、免疫学性质的对比研究,证实二者在SDS-PAGE中电泳带位置一致、分子量相同,纯度达99%;在反相HPLC中出峰行为一致,纯度达100%;在半干式聚焦电泳分析中电泳带分布相同,等电点为7.91.rBSN端起的20个氨基酸序列为TPQNITDLCAEYHNTQIHTL,与克隆基因来源株的毒素B亚单位同一段序列完全一致.氨基酸组成分析证实rBS与BS相近.在免疫学性质分析中,rBS与BS在免疫双扩散试验中与抗CT均出一条沉淀线且相互吻合;在免疫电泳试验中二者与抗CT在相应位置上产生一条沉淀弧;二者均能与神经节苷脂GM1结合且这种结合均可通过二者与抗CT的预保温处理而被阻断.对比研究结果揭示rBS与BS性质完全一致,可代替BS用于? An engineered bacterium strain E.coli MM2(pMM CTB)which secrete cholera toxin B subunit at high level has been constructed by recombinant DNA technigue.It was confirmed that the strain was maintained to secrete the recombinant cholera toxin B subunit(rBS)as original by fermentation in 50 L fermentor(type MSJ U3 made in Japan).In order to use the rBS as a novel type of cholera vaccine,adjuvant and protein carrier,its characters must be checked against those of native cholera toxin B subunit(BS)in chemistry and physics and immunity.The pure rBS was prepared by affinity chromatography from culture supernatant of E.coli MM2,which was obtained in a few batches of products by fermentation.The characters of purified rBS were checked under similar conditions against those of native BS purchased from Sigma.Both rBS and BS exhibited one protein band by SDS PAGE,and were in the same position on polyacrylamide gel with M r 11 677.The purity of purified rBS was 98 76%(stained by Coomassie blue)or 99 16%(silver staining).The peak behavior of rBS in HPLC was identical with that of the native B subunit.The purity of rBS in HPLC was 100%.Analysis of the 20 amino acid residues from N terminal of rBS was TPQNITDLCAEYHNTQIHTL which was homologous with that of the natural B subunit of Vibrio cholerae 569B.The amino acid composition analysis of the rBS showed no deferences with that of the native B subunit.The contents of a few of amino acids were lower than theoretical value due to their instability or destruction in hydrolysis under acid condition.No rise in the values was detected.Antigenicity studies indicated that the engineered B subunit gave a single precipitation line which connected the line formed by the natural B subunit.The same finding was observed in the microimmunoelectrophoresis.The rBS could bind the receptor ganglioside GM1 in GM1 ELISA and this binding could be blocked by preincubation of rBS with antiserum angainst cholera toxin.In summary,It is demonstrated that the characters of rBS are identical with those of native BS in physics and chemistry and immunity,thus,the rBS can be used in vaccine and as adjuvant and protein carrier to replace BS.
出处 《中国生物化学与分子生物学报》 CAS CSCD 1999年第2期316-319,共4页 Chinese Journal of Biochemistry and Molecular Biology
基金 国家863资助
关键词 重组 霍乱毒素B 亚单位 性质 Character Recombinant cholera toxin B subunit Cholera toxin B subunit
  • 相关文献

参考文献10

  • 1张艳红 刘传暄 等.免疫亲和层析法大量制备高纯度工程菌产霍乱毒素B亚单位[J].中华流行病学杂志,1992,13(2):142-144.
  • 2刘传暄 张艳红 等.胞壁酰二肽和肽聚糖对微量霍乱毒素免疫家兔的增效作用[J].中华流行病学杂志,1992,13(2):140-142.
  • 3刘传暄,马清钧.GM1—ELISA检测霍乱毒素及有关肠毒素的研究[J].中华微生物学和免疫学杂志,1989,9(1):62-65. 被引量:5
  • 4夏其昌.活性大分子蛋白质的检测分析[J].生物工程进展,1992,:85-92.
  • 5夏其昌,生物工程进展,1992年,增刊,85页
  • 6刘传暄,中华流行病学杂志,1992年,13卷,增2期,140页
  • 7张艳红,中华流行病学杂志,1992年,13卷,增2期,142页
  • 8Ma Qingjun,Sci China B,1991年,34卷,274页
  • 9Ma Qingjun,Sci China B,1989年,32卷,186页
  • 10刘传暄,中华微生物学和免疫学杂志,1989年,9卷,62页

共引文献4

同被引文献11

  • 1林厚怡,宋兰珍,佘雪轩.离子交换柱层析分离霍乱类毒素[J].南京医科大学学报(自然科学版),1994,14(3):304-306. 被引量:1
  • 2刘吏婷,江海燕,颜艳,崔平,王希良,王建华.以霍乱毒素重组B亚单位为佐剂的流感抗原滴鼻免疫效果研究[J].西北农业学报,2007,16(4):202-205. 被引量:3
  • 3CuelIo M,Cabrera O,del Campo JM,et al.Mucosal immune respanses to meningococcal C polysaccharide-protein conjugate in mice.Vaccine,2006,24 (Suppl 2):S72-73.
  • 4Jobling MG,Holmes RK.Mutational analysis of ganglioside GM (1) -binding ability,pentamer formation,and epitopes of cholera toxin B (CTB) subunits and CTB/heat-labile enterotoxin B subunit chimeras.Infect Immun,2002,70(3):1260-1271.
  • 5Bergquist C,Lsgergard T,Holmgren J.Antibody responses in serum and lung to intranasal immunization with Haemophilus influenzae type b polysaccharide conjugated to cholera toxin B subunit and tetanus toxoid.APMIS,1998,106(8):800-806.
  • 6Sun JB,Bask C,Olsson T,et al.Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjngated to cholera toxin B subunit.Proc Natl Acad Sci USA,1996,93(14):7196-7201.
  • 7Shen X,Lagergrad T,Yang Y,et al.Systemic and mucosal immune responses in mice after mucosal immunization with group B streptococcus type Ⅲ capsular polysaccharide-cholera toxin B subunit conjugate vaccine.Infect Immun,2000,68(10):5749-5755.
  • 8Westerink MA,Smithson SL,Srivastava N,et al.ProJuvant (Pluronic F127/chitosan) enhances the immune response to intranasally administered tetanus toxoid.Vaccine,2001,20 (5-6):711-723.
  • 9Bergquist C,Lagergard T,Holmgren J.Anticarrier immunity suppresses the antibody response to polysaccharide antigens after intranasal immunization with the polysaccharide-protein conjugate.Infect Immun,1997,65(5):1579-1583.
  • 10(美)J.萨姆布鲁克(J.Sambrook)等著,金冬雁等.分子克隆实验指南[M]科学出版社,1992.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部